Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sagopilone in Recurrent Glioblastoma
NCT00397072Phase 2Completed
- Sponsor
- Carlo Besta Neurological Institute
- Start
- Jun 2006
- Primary completion
- Mar 2008
- Countries
- 1
01
Overview
A Phase 2 trial of sagopilone in glioblastoma (GBM), sponsored by Carlo Besta Neurological Institute. Started Jun 2006; status: completed.
02
Drugs
sagopilone
03
Conditions
glioblastoma (GBM)
Beyond the preview
Go deeper on NCT00397072.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00397072.